Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06367998
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-11
Brief Title:
Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair
Sponsor:
The Catholic University of Korea
Organization:
The Catholic University of Korea
Study Overview
Official Title:
The Effect of Pregabalin on Shoulder Pain of Patients With Myofascial Pain Syndrome and Central Sensitization Who Undergo Arthroscopic Rotator Cuff Repair
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the effects of Pregabalin intake on shoulder pain management in patients with central sensitization undergoing arthroscopic rotator cuff repair Although Pregabalin is known to be effective in controlling pain after shoulder arthroscopy research on its efficacy in pain management for patients with central sensitization is scarce Utilizing a list that identifies central sensitization this study will explore whether Pregabalin can reduce postoperative pain in these patients and potentially improve joint mobility emotional and physical functioning A prospective randomized study is planned with inclusion criteria set for patients aged between 19 and 70 who have undergone arthroscopic rotator cuff repair
The study will compare clinical outcomes up to one year postoperatively between two groups of 38 patients each The case group will receive standard postoperative medications NSAIDs plus Pregabalin oral intake from the day before surgery to six weeks postoperatively while the control group will receive only the standard postoperative medications without Pregabalin
The study will compare clinical outcomes up to one year postoperatively between two groups of 38 patients each The case group will receive standard postoperative medications NSAIDs plus Pregabalin oral intake from the day before surgery to six weeks postoperatively while the control group will receive only the standard postoperative medications without Pregabalin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None